EUVIMEDEUVIMED entdecken
Multizentrische Studie

Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study

Shuqin Sun, Yanfei Yu, Wenjing Feng, Luyan Sun, Shuo Yang

Modern Rheumatology · 2025

DOI: 10.1093/mr/roae066 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Shuqin Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Dermatomyositis, Hemoperfusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Haemoperfusion (HP) is used to treat various diseases, including sepsis and acute respiratory distress syndrome. However, few studies have explored the efficiency of HP in dermatomyositis-associated acute exacerbation of interstitial lung disease.

Methods

We conducted a retrospective study. Two hundred and sixteen patients with dermatomyositis-associated acute exacerbation of interstitial lung disease were included. Patients were divided into the HP group (treatment group) and the control group. Changes in oxygenation, haemodynamic parameters, lung ultrasound scores, and inflammatory cytokine levels were evaluated before and after HP in the treatment group. The length of intensive care unit (ICU) stays, duration of ventilator therapy, mortality rate, and incidence of complications were compared between the treatment and control groups.

Results

Haemodynamic and oxygenation variables in the treatment group significantly improved after treatment. However, the levels of the inflammatory factors significantly decreased after treatment. The length of ICU stay and the duration of ventilator therapy were significantly shorter in the treatment group than in the control group. The mortality rate of the treatment group was significantly lower than that of the control group.

Conclusions

This study demonstrated that HP could improve treatment efficacy in patients with dermatomyositis-associated acute exacerbation of interstitial lung disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialDermatomyositisHemoperfusionHumansRetrospective StudiesMaleFemaleMiddle AgedTreatment OutcomeAdultAgedLength of StayDisease ProgressionIntensive Care UnitsRespiration, Artificial

Stichwörter der Autor:innen

Dermatomyositishaemoperfusioninterstitial lung disease

Autor:innen und Institutionen

  • Department of Geriatric Medicine, Affiliated Hospital of Qingdao University, Qingdao, China.
  • Department of Critical Care Medicine, Affiliated Hospital of Qingdao University, Qingdao, China.
  • Department of Oral Medicine, Affiliated Hospital of Qingdao University, Qingdao, China.

Zitieren

APA

Sun, S., Yu, Y., Feng, W., Sun, L., & Yang, S. (2025). Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study. Modern Rheumatology. https://doi.org/10.1093/mr/roae066

Vancouver

Sun S, Yu Y, Feng W, Sun L, Yang S. Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study. Modern Rheumatology. 2025. doi:10.1093/mr/roae066

BibTeX
@article{Sun2025,
  author = {Sun, Shuqin and Yu, Yanfei and Feng, Wenjing and Sun, Luyan and Yang, Shuo},
  title = {Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study},
  journal = {Modern Rheumatology},
  year = {2025},
  doi = {10.1093/mr/roae066}
}
Kostenlos starten →